Published in Cancer Weekly, May 31st, 2005
According to recent research from the Netherlands, "We analyzed causes of death, other than resistant disease or relapse, in 875 children with ALL and 229 with AML, treated on three different Dutch Childhood Oncology Group (DCOG) ALL and three AML protocols. Overall, 23 (2.6%) ALL and 44 (19.2%) AML patients died. Early death (ED, before remission was reached) occurred in 9 ALL (1%) and 30 AML (13.1.%) patients, including 3 and 10 deaths before treatment was initiated."
"Chemotherapy-related mortality in remission (CRM) occurred in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.